This work is licensed under a Creative Commons Attribution 4.0 International License.
AmphiArc2 Off2.2.4
General Information
DRACP ID DRACP02793
Peptide Name AmphiArc2 Off2.2.4
Sequence QVLKKVRTWYRKAFHVIGKV
Sequence Length 20
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | EC50=68 ± 5 µM | MTT assay | 24 h | 1 |
| A549 | Lung adenocarcinoma | Carcinoma | EC50= µM | MTT assay | 24 h | 1 |
Hemolytic Activity Human erythrocytes: HC50>200 µM
Normal (non-cancerous) Cytotoxicity HDMEC: EC50>100 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C117H190N34O24
Absent amino acids CDEMNPS
Common amino acids KV
Mass 279609
Pl 11.84
Basic residues 7
Acidic residues 0
Hydrophobic residues 9
Net charge 7
Boman Index -3089
Hydrophobicity -24.5
Aliphatic Index 102
Half Life
Mammalian: 3.5 hour
Yeast: 10 min
E.coli: >10 hour
Extinction Coefficient cystines 6990
Absorbance 280nm 367.89
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31375699
Title In silico design and optimization of selective membranolytic anticancer peptides
Doi 10.1038/s41598-019-47568-9
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_16618
This work is licensed under a Creative Commons Attribution 4.0 International License.